The synthetic hallucinogen, 2C-B, which has been sold in Latin American and Caribbean regions as “cocaina rosada” can result in a range of undesirable outcomes.Medication offered as “pink copyright” could include any number of medicine and additives able to creating mild to significant consequences on wellness.Among the first potential risk